(Q45993570)

English

A phase II study of oral idarubicin (4-demethoxydaunorubicin) in advanced breast cancer.

scientific article published in January 1988

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/3163529

A phase II study of oral idarubicin (4-demethoxydaunorubicin) in advanced breast cancer. (English)

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/3163529

author name string

N S Stuart

1

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/3163529

M H Cullen

2

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/3163529

T J Priestman

3

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/3163529

G R Blackledge

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/3163529

C J Tyrrell

5

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/3163529

publication date

1 January 1988

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/3163529

Cancer Chemotherapy and Pharmacology

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/3163529

21

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/3163529

4

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/3163529

351-354

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/3163529

Idarubicin in advanced breast cancer: a phase II study

1 reference

https://pubmed.ncbi.nlm.nih.gov/3163529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

New anthracycline analogs in advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3163529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of oral 4-demethoxydaunorubicin in previously treated (except anthracyclines) metastatic breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/3163529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antileukemic activity of 4-demethoxydaunorubicin in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/3163529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic activity of 4-demethoxydauno-rubicin (idarubicin) in adult acute leukemia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/3163529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase-II trial of oral idarubicin (4-demethoxydaunorubicin) in advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3163529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I clinical evaluation of oral and intravenous 4-demethoxydaunorubicin

1 reference

https://pubmed.ncbi.nlm.nih.gov/3163529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis and antitumor activity of 4-demethoxydaunorubicin, 4-demethoxy-7,9-diepidaunorubicin, and their beta anomers

1 reference

https://pubmed.ncbi.nlm.nih.gov/3163529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II trial with oral idarubicin in advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3163529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase II study of idarubicin given orally in the treatment of anthracycline-naive advanced breast cancer patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/3163529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I trial of 4-demethoxydaunorubicin (idarubicin) with single oral doses

1 reference

https://pubmed.ncbi.nlm.nih.gov/3163529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of Biochemical and Biological Methods in the Evaluation of New Anthracycline Drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/3163529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activity of 4-demethoxydaunorubicin by the oral route in advanced breast cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3163529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reporting results of cancer treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/3163529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antitumor activity of 4-demethoxydaunorubicin administered orally

1 reference

https://pubmed.ncbi.nlm.nih.gov/3163529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phase I and clinical pharmacology studies of intravenous and oral administration of 4-demethoxydaunorubicin in patients with advanced cancer

1 reference

https://pubmed.ncbi.nlm.nih.gov/3163529

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/BF00264204

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/3163529

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

18 December 2017

http://europepmc.org/abstract/MED/3163529

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45993570&oldid=2207513522"